Confused between eczema and psoriasis? Experts explain how these skin conditions differ in symptoms, causes, and treatment.

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...

By Sriparna Roy March 18 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI 100 (41.0%, 39.5%)Quality‑of‑life improvements and itch ...

Spongiotic dermatitis is a pathological term that refers to a non-contagious skin inflammation, which is often present in eczema, dermatitis, and allergic contact dermatitis.

"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms ...

Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...

A healthy skin is not only a matter of appearance becuase itchy and inflamed skin may impact sleep, mood and overall ...

71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...

Alumis (NASDAQ:ALMS) used a virtual key opinion leader event from the American Academy of Dermatology (AAD) Congress to ...